Fanetizole

CAS No. 79069-94-6

Fanetizole( —— )

Catalog No. M22251 CAS No. 79069-94-6

Fanetizole shows immunoregulating activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 32 In Stock
5MG 29 In Stock
10MG 41 In Stock
25MG 73 In Stock
50MG 107 In Stock
100MG 161 In Stock
200MG 240 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Fanetizole
  • Note
    Research use only, not for human use.
  • Brief Description
    Fanetizole shows immunoregulating activity.
  • Description
    Fanetizole shows immunoregulating activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    79069-94-6
  • Formula Weight
    280.39
  • Molecular Formula
    C17H16N2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(Cc1ccccc1)Nc2nc(c[s]2)c3ccccc3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Styrt B , Rocklin R E , Klempner M S . Inhibition of neutrophil superoxide production by fanetizole[J]. Inflammation, 1985, 9(3):233-44.
molnova catalog
related products
  • Benzoylpaeoniflorin

    Benzoylpaeoniflorin is active against cyclooxygenase-1 and cyclooxygenase-2 enzymes.

  • SM-102

    SM-102 is an ionizable amino lipid that can be used for the formation of lipid nanoparticles (LNPs). SM-102 has the potential for development of lipid nanoparticles for delivery of mRNA-based vaccines.

  • RMC-6291

    RMC-6291 is an orally active, covalent inhibitor of KRAS G12C (ON) that forms a tri-complex within tumor cells between KRAS G12C (ON) and cyclophilin A (CypA), thereby preventing KRAS G12C (ON) from signaling via steric blockade of RAS effector binding and eliciting deep and durable suppression of RAS pathway activity in KRAS G12C tumor models .